Nothing bugs Cubist CEO Michael Bonney
By Val Brickates Kennedy, MarketWatch
Media
Showing Media Items: 1–8 of 8
17
Jan
9
Nov
Cubist-sponsored Battling Superbugs micro site launched
Cubist has launched a new website, www.Battlingsuperbugs.com, providing interested parties with a resource on multidrug-resistant (MDR) pathogens. Concern is growing about the public health threat caused by infections due to a growing array of MDR pathogens. This website brings together the views of physicians, scientists, policy experts and others about the problem and what we can do about it. We are very excited about this micro site, and hope it will provide a valuable resource and information repository as well as help elevate Cubist as a thought leader. The corporate communications team welcomes thoughts on the site overall, the content, layout, and areas of focus.
21
Oct
Infectious Disease Special Edition
Barry Eisenstein, M.D. article in Infectious Disease Special Edition-September 2009
8
Sep
"Raising the Roof" Beam Signing
On September 8, 2010, Massachusetts Governor Deval Patrick and other state and local officials joined more than 200 employees to commemorate an important milestone in Cubist history - the official start of the 65 Hayden Avenue Expansion project. Cubist is raising the roof of its Lexington R&D facility in order to add two floors of new lab space by early 2012 that will eventually accommodate 150 additional scientists and support roles.
19
May
Mike Bonney Co-authors Article on Finding STEM Educators
Mike Bonney and Pat Kirby, executive director of Citizen Schools Massachusetts, co-authored an article for CommonWealth Magazine, called "Tap colleges, firms for STEM educators," that explores ways to enlist STEM (Science, Technology, Engineering, Math) professionals around the country to help close the STEM achievement gap between students in the U.S. and those in other developed countries. Mike and Pat cite the recent success of Citizen Schools as an example, and reason that such effort would benefit not only the K-12 children of today, but also companies looking to hire the well-qualified employees of tomorrow.
15
Mar
Michael Bonney Honored by Massachusetts Biotechnology Council with its 2010 Innovative Leadership Award
LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that its President and CEO Michael Bonney will be honored with the second annual Massachusetts Biotechnology Council (MassBio) Innovative Leadership Award. Mr. Bonney will receive this recognition at an awards luncheon at the MassBio Annual Meeting on March 31st at the Seaport World Trade Center in Boston.
1
Feb
CID 2010 - Daptomycin: From the Mountain to the Clinic
CID 2010 - Daptomycin: From the Mountain to the Clinic, supplemental article authored by Cubist's Barry Eisenstein, Frederick Oleson, Jr., and Richard Baltz